Asia Pacific Pharmaceutical Filtration Market

The Asia Pacific pharmaceutical filtration market is projected to reach USD 5.58 billion by 2030 from USD 3.50 billion in 2025, at a CAGR of 9.7%. Growth in the Asia Pacific pharmaceutical filtration market can be attributed to several key factors, including the rapid expansion of biologics & vaccine manufacturing in the Asia Pacific region and the growing CDMO/CMO footprint.

To know about the assumptions considered for the study download the pdf brochure

Key players in the Asia Pacific pharmaceutical filtration industry with a strong footprint include Asahi Kasei Corporation (Japan), Depth Filtration Technologies Pvt. Ltd. (India), Advanced Microdevices Pvt. Ltd. MDI (India), Axiva Sichem Pvt. Ltd. (India), Brother Filtration (China), KEL Filters (India), Osmotech Membranes Pvt. Ltd. (India), and Star Filter Industry (India), among others. Manufacturers are moving beyond traditional membrane and depth filters to build portfolios around high-performance solutions for single-use bioprocessing, virus removal, and sterile fill-finish steps, tailored to complex biologics and next-generation therapies. By adding new production capacity, forging regional partnerships, and upgrading to automated, data-rich filtration platforms, these companies aim to expand their footprint, tighten contamination control, support continuous and hybrid processing, and deliver integrated systems that raise manufacturing efficiency while simplifying validation and regulatory compliance for biopharma customers.

In May 2024, Asahi Kasei Medical completed its third assembly plant for Planova virus removal filters in Nobeoka, Japan, boosting production capacity for hollow-fiber depth-like virus filters used in biotherapeutic manufacturing and strengthening supply reliability.

In May 2023, Asahi Kasei introduced new Microza depth filter membranes designed for applications including pharmaceutical and biotechnology processing, expanding its depth filtration portfolio for high-capacity liquid clarification and impurity removal.

Asahi Kasei Corporation (Japan)

Asahi Kasei Corporation is a major Japanese manufacturer of pharmaceutical filtration solutions, including Microza hollow-fiber membranes, sterile filters, and biologic & vaccine clarification solutions. The firm specializes in developing high-throughput, fouling-resistant filtration systems that aid in intensified upstream and downstream processes. With increasing investments in Japan and the APAC region, Asahi Kasei offers dependable and regulation-compliant filtration solutions that feature enhanced capabilities in terms of yield, scalability, processing efficiency, and robustness, thereby securing a more significant role in supporting the development of biologics, biosimilars, and advanced therapies within this evolving manufacturing ecosystem.

 Depth Filtration Technologies Pvt. Ltd. (India)

Depth Filtration Technologies Pvt. Ltd. offers high-performance clarifying and prefiltration solutions for pharmaceutical and bioprocess industries. To manage excessive solids loading, improve clarity, and safeguard purification processes, the company provides depth filter cartridges, modules, and filtration assemblies. It facilitates fermentation-based production, biologics, and vaccines, with a focus on reducing fouling, maintaining consistent throughput, and improving operating efficiency. Clients may achieve dependable, scalable, and economical filtration across development and commercial production due to its growing product portfolio and application knowledge.

Advanced Microdevices Pvt. Ltd. (MDI) (India)

Advanced Microdevices Pvt. Ltd. (MDI) is a leading Indian filtration manufacturer, offering membranes, capsule filters, syringe filters, and sterile filtration systems for the pharmaceutical and bioprocessing industries. Known for cost-effective, GMP-compliant solutions, MDI supports domestic manufacturers with reliable clarification and sterilizing-grade filtration. Its in-house membrane production, strong quality systems, and expanding single-use portfolio enable customized, fast-turnaround solutions. MDI’s competitive pricing, robust supply chain, and technical capabilities make it a preferred supplier for India’s growing biologics, vaccines, and injectables market.

Market Ranking

The Asia Pacific pharmaceutical filtration market is further strengthened by the presence of established players such as Asahi Kasei Corporation (Japan), Depth Filtration Technologies Pvt. Ltd. (India), Advanced Microdevices Pvt. Ltd. MDI (India), Axiva Sichem Pvt. Ltd. (India), and Brother Filtration (China), each contributing specialized filtration technologies tailored to the region’s stringent manufacturing and regulatory demands.

Asahi Kasei enhances the pharmaceutical filtration landscape through its Microza hollow-fiber membranes, sterilization-grade filters, and virus removal platforms that support the manufacturing of high-density biologics, vaccines, and plasma-derived therapeutics, backed by strong application expertise and technical centers. Depth Filtration Technologies Pvt. Ltd. offers high-capacity depth filter cartridges and clarification systems optimized for cell culture harvest and fermentation applications, providing reliable solids retention and scalable prefiltration performance for downstream protection. Advanced Microdevices Pvt. Ltd. (MDI) expands its regional capabilities with a broad range of membrane filters, cartridge systems, and single-use sterile filtration assemblies, supported by in-house membrane production that ensures quality consistency and a dependable supply for injectables, vaccines, and biologics. Axiva Sichem enhances accessibility with cost-efficient PES, PTFE, and PVDF filtration devices widely adopted in research, formulation, and small-scale bioprocessing settings, delivering GMP-aligned sterilization and clarification solutions for India’s expanding pharmaceutical sector. Brother Filtration reinforces the ecosystem with competitively priced pleated cartridges, high-flow systems, and polymeric membrane filters designed for pharmaceutical water systems, media preparation, and process liquid filtration, supported by strong distribution networks across Asia. Together, these companies broaden the Asia Pacific pharmaceutical filtration market with scalable technologies, regional manufacturing strength, and customer-centric technical support.

The Asia Pacific pharmaceutical filtration market is evolving quickly as manufacturers invest in high-purity membranes, single-use filtration systems, automated controls, and integrated bioprocess platforms to support modern production lines. The rising demand for biologics, cell & gene therapies, and other high-value sterile drugs, combined with tighter regulations on contamination control and product safety, is a key driver of this growth. The rest of the market is made up of regional filtration suppliers and niche technology firms that are scaling through focused innovation, local partnerships, and customized solutions designed for small and mid-size biomanufacturers, emerging therapy developers, and sites that need flexible, application-specific filtration capabilities.

Related Reports:

Asia Pacific Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies, System (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User-Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com